Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell Epitopes-Reference-Cited by-同舟云学术

Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell Epitopes

Published:2019-08-21 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Sefrin Julian P.,Hillringhaus Lars,Mundigl Olaf,Mann Karin,Ziegler-Landesberger Doris,Seul Heike,Tabares Gloria,Knoblauch Dominic,Leinenbach Andreas,Friligou Irene,Dziadek Sebastian,Offringa Rienk,Lifke Valeria,Lifke Alexander

Funder

F. Hoffmann-La Roche

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

2. Towards a systems understanding of MHC class I and MHC class II antigen presentation;Neefjes;Nat Rev Immunol,2011

3. Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphoma;DiJoseph;Clin Cancer Res,2006

4. Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma;Dornan;Blood,2009

5. The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo;Ikeda;Clin Cancer Res,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces;mAbs;2024-03-18

2. The present and future of bispecific antibodies for cancer therapy;Nature Reviews Drug Discovery;2024-03-06

3. Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells;Cancer Gene Therapy;2023-11-09

4. Cytotoxic CD4+ T cells in chronic viral infections and cancer;Frontiers in Immunology;2023-10-25

5. EBV-induced T-cell responses in EBV-specific and nonspecific cancers;Frontiers in Immunology;2023-09-29